Here is the title one h1 placeholder text

On the evening of April 25, Guoen Co., Ltd. completed the disclosure of the 2021 annual report, in the face of the complex external environment in 2021, the company actively grasped the opportunity, had the courage to meet the challenge, and achieved an annual operating income of 9.766 billion yuan, a year-on-year increase of 35.99%, approaching the 10 billion mark and hitting a record high again! 

In 2021, the company made a precise layout in the upstream field, successfully controlled Dongbao Biotechnology, a listed company on the Growth Enterprise Market in the field of big health, and strategically invested in chemical raw material sector projects such as Zhejiang Yisu and Jiangsu Guoheng, forming a new strategic development pattern of "one body and two wings" with the national grace industrial platform as the center, long-term scale efficiency as the goal, and large chemical industry and big health industry as the two wings.

Continue to build a vertically integrated platform

In terms of the large chemical industry, in 2021, with the help of the industry-leading vertical integration professional platform of new materials, Guoen Co., Ltd. will continue to improve the upstream and downstream industrial chain, continue to enrich the product structure, continue to optimize the customer base, gradually expand the company's scale, and steadily grow in various business segments such as chemical raw materials, polymer modified materials, composite materials, degradable materials, light display materials, artificial turf, and medical protective materials.

In 2021, Guoen Co., Ltd. successfully entered the chemical raw material business based on polystyrene and polypropylene through strategic investment in Zhejiang Yisu and Jiangsu Guoheng, and efficiently collaborated with Guoen Co., Ltd. in the application field of modified materials, highlighted the scale advantage of upstream and downstream integration, and further enhanced market competitiveness, which is an important measure for the company to comprehensively build an industrial spatial pattern of large chemical and fine chemicals.

While developing the upstream, the company actively grasps the opportunity of the rapid development of the new energy automobile industry in the downstream of the industry, and focuses on the development of new energy vehicles and storage, lithium batteries and other product sectors in the polymer modification business. In terms of composite materials business, the supply of the company's charging pile series products has been greatly increased, and the application of related processes in the new energy ultra-thin battery package has established strategic cooperation with the leading enterprises of new energy power batteries, which will become an important pole of the composite materials sector in the future.

In terms of medical protective materials business, the subsidiary Guoen Meltblown Industry has continued to strengthen cooperation with customers such as Honeywell, Sinopharm Ogilvy, Rizhao Sanqi, Weigao Medical Materials, Yingke Medical, and Wenwen Medical. During the 2022 Beijing Winter Olympics, it exclusively provided filter materials for the "China Ice and Snow" series masks of the Winter Olympics, demonstrating the excellent quality of the company's products and winning a good market reputation.

Continuously deepen the industrial strategic layout

In terms of the big health industry, in 2021, after the company completed the acquisition of Dongbao Biotechnology, through the acquisition of a controlling stake in Yiqing Biology by Dongbao Biotechnology, it completed the integration of internal resources, opened up the gelatin industry chain, and realized the vertical integration extension, and initially completed the strategic layout of gelatin, biomedicine, medical cosmetology, personal care and other sub-industries in the big health industry, and realized the in-depth coverage of downstream pharmaceutical excipients, health care products and medical beauty products.

In 2021, Dongbao Bio's gelatin sales and sales revenue increased by 29.56% and 34.53% year-on-year respectively, and the annual sales volume of gelatin exceeded 10,000 tons for the first time, with a significant increase in market share and further release of brand effect. The company has increased its efforts to expand the downstream high-end market, and has improved the market in new fields such as dairy products and candy, and the special-purpose gelatin has also been sold in the soft capsule market, laying a good foundation for the multi-dimensional development of the follow-up big health market.

In terms of collagen business, Dongbao Biotech has upgraded its existing products, further promoted the implementation of the "collagen +" strategy, focused on the promotion of the "Yuansu" brand, and used celebrity endorsement for the first time, striving to build "the first brand of national collagen". "Dongbao/Yuansu" entered the list of top 100 brands in Inner Mongolia in 2021 with a brand value of 1.723 billion yuan.

In 2021, Guoen Group actively implemented the strategic plan of external strategic investment, integration of internal resources, extension of the industrial chain, improvement of the value chain, and construction of the ecological chain. In the future, the company will continue to achieve high-quality and leapfrog development of Guoen Group through the new strategic pattern of "one body and two wings" with the vertical integration of the Guoen industrial platform as the strategic system and the large chemical industry and the big health industry as the two wings!